References

Global cancer incidence and mortality rates and trends—an update

10.1158/1055-9965.epi-15-0578 · 2016 · External reference

Cancer in developing countries: the next most preventable pandemic. The global problem of cancer

10.1016/j.critrevonc.2013.03.011 · 2013 · External reference

The global cancer burden and human development: a review

10.1177/1403494817715400 · 2018 · External reference

Global cancer prevention: an important pathway to global health and development

10.1016/j.puhe.2011.09.029 · 2011 · External reference

Global health inequalities and breast cancer: an impending public health problem for developing countries

10.1111/j.1524-4741.2008.00618.x · 2008 · External reference

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

10.3322/caac.21660 · 2021 · External reference

The global concern for cancer emergence and its prevention: a systematic unveiling of the present scenario

10.1007/978-3-031-28780-0_60 · 2023 · External reference

Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice

10.1038/s41571-023-00744-3 · 2023 · External reference

Current cancer epidemiology

10.2991/jegh.k.191008.001 · 2019 · External reference

Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020

10.1097/cm9.0000000000001474 · 2021 · External reference

Global, regional, and national lifetime risks of developing and dying from gastrointestinal cancers in 185 countries: a population-based systematic analysis of GLOBOCAN

10.1016/s2468-1253(23)00366-7 · 2024 · External reference

Global, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990–2019

10.1186/s13045-021-01213-z · 2021 · External reference

Burden of six major types of digestive system cancers globally and in China

10.1097/cm9.0000000000003225 · 2024 · External reference

A global perspective of cancer prevalence: The causative agent, the environment, or the genes

10.1007/978-3-030-80962-1_100-1 · 2023 · External reference

Advancements and limitations in traditional anti-cancer therapies: a comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapy

10.1007/s12672-025-02198-8 · 2025 · External reference

Cancer treatment therapies: traditional to modern approaches to combat cancers

10.1007/s11033-023-08809-3 · 2023 · External reference

Comprehensive overview of therapeutic strategies in colon cancer: chemotherapy, targeted therapy, and immunotherapy

10.1002/cbf.70196 · 2026 · External reference

Cutting-edge approaches for targeted drug delivery in breast cancer: beyond conventional therapies

10.1039/d4na00086b · 2024 · External reference

Breakthroughs in modern cancer therapy and elusive cardiotoxicity: critical research‐practice gaps, challenges, and insights

10.1002/med.21463 · 2018 · External reference

Molecular mechanisms and therapeutic strategies in overcoming chemotherapy resistance in cancer

10.1186/s43556-024-00239-2 · 2025 · External reference

ATP‐binding cassette (ABC) transporters in cancer: a review of recent updates

10.1111/jebm.12434 · 2021 · External reference

ABC transporters in breast cancer: their roles in multidrug resistance and beyond

10.1002/9780470423936.ch8 · 2022 · External reference

The therapeutic potential of targeting ABC transporters to combat multi-drug resistance

10.1080/14728222.2017.1310841 · 2017 · External reference

Overcoming chemotherapy resistance in metastatic cancer: a comprehensive review

10.3390/biomedicines12010183 · 2024 · External reference

Acquired resistance in cancer: towards targeted therapeutic strategies

10.1038/s41568-025-00824-9 · 2025 · External reference

Drug resistance and combating drug resistance in cancer

10.20517/cdr.2019.10 · 2019 · External reference

The challenge of drug resistance in cancer treatment: a current overview

10.1007/s10585-018-9903-0 · 2018 · External reference

Drug resistance and cancer stem cells

10.1186/s12964-020-00627-5 · 2021 · External reference

Emerging therapeutic strategies to overcome drug resistance in cancer cells

10.3390/cancers16132478 · 2024 · External reference

Drug-metabolizing enzymes: role in drug resistance in cancer

10.1007/s12094-020-02325-7 · 2020 · External reference

The role of ABC transporters in drug resistance, metabolism and toxicity

10.2174/1567201043480036 · 2004 · External reference

Natural product based anticancer drug combination discovery assisted by deep learning and network analysis

10.3389/fntpr.2023.1309994 · 2024 · External reference

Rising above: exploring the therapeutic potential of natural product-based compounds in human cancer treatment

10.53388/tmr20240618001 · 2025 · External reference

Exploring natural products as apoptosis modulators in cancers: insights into natural product-based therapeutic strategies

10.1007/s00210-025-03876-8 · 2025 · External reference

Cheminformatics in natural product‐based drug discovery

10.1002/minf.202000171 · 2020 · External reference

Role of natural products in developing novel anticancer agents: a perspective

10.1002/cbdv.202200535 · 2022 · External reference

Microbes and cancer

10.1146/annurev-immunol-051116-052133 · 2017 · External reference

Microbes and cancer: friends or faux

10.3390/ijms21093115 · 2020 · External reference

Role of signaling pathways in the interaction between microbial, inflammation and cancer

10.1007/s44178-023-00064-7 · 2023 · External reference

Microbial and metabolic profiles unveil mutualistic microbe-microbe interaction in obesity-related colorectal cancer

10.1016/j.xcrm.2024.101429 · 2024 · External reference

Metabolic modeling of host–microbe interactions for therapeutics in colorectal cancer

10.1038/s41540-021-00210-9 · 2022 · External reference

The interaction between microbes and cytokines in cancer: unraveling the underlying effects

10.1186/s12967-026-08174-2 · 2026 · External reference

Microbial interactions and interventions in colorectal cancer

10.1128/9781555819705.ch4 · 2018 · External reference

Cancer-promoting effects of microbial dysbiosis

10.1007/s11912-014-0406-0 · 2014 · External reference

Crosstalk between intratumoral microbes and tumor immunity: implications for tumor therapy

10.1002/cam4.71575 · 2026 · External reference

Metabolic interactions: how gut microbial metabolites influence colorectal cancer

10.3389/fmicb.2025.1611698 · 2025 · External reference

Efficacy of probiotics, paraprobiotics, and postbiotics in colorectal cancer cell line and their role in immune response

10.1590/1806-9282.20240226 · 2024 · External reference

Lactic acid bacteria-derived postbiotics as adjunctive agents in breast cancer treatment to boost the antineoplastic effect of a conventional therapeutic comprising tamoxifen and a new drug candidate: an aziridine–hydrazide hydrazone derivative

10.3390/molecules29102292 · 2024 · External reference

Anticarcinogenic potential of probiotic, postbiotic metabolites and paraprobiotics on human cancer cells

10.1007/978-981-16-0223-8_6 · 2021 · External reference

Human commensal bacteria: next-generation pro-and post-biotics for anticancer therapy

10.31083/fbe26809 · 2025 · External reference

Recent advances in the area of plant-based anti-cancer drug discovery using computational approaches

10.1007/s11030-022-10590-7 · 2024 · External reference

Discovering anti-cancer drugs via computational methods

10.3389/fphar.2020.00733 · 2020 · External reference

Computational drug discovery of medicinal compounds for cancer management

10.3389/978-2-8325-4180-7 · 2023 · External reference

Computational approaches: a new frontier in cancer research

10.2174/0113862073265604231106112203 · 2024 · External reference

Anticancer drug discovery based on natural products: from computational approaches to clinical studies

10.3390/biomedicines12010201 · 2024 · External reference

Circular and leaderless bacteriocins: biosynthesis, mode of action, applications, and prospects

10.3389/fmicb.2018.02085 · 2018 · External reference

Quorum sensing circuits in the communicating mechanisms of bacteria and its implication in the biosynthesis of bacteriocins by lactic acid bacteria: a review

10.1007/s12602-019-09555-4 · 2020 · External reference

The microbiome-shaping roles of bacteriocins

10.1038/s41579-021-00569-w · 2021 · External reference

Lactic acid bacteria bacteriocins: classification, biosynthesis, health benefits, and strategies for enhanced efficacy

10.1021/acs.jafc.5c14047 · 2026 · External reference

Bacteriocins of lactic acid bacteria: extending the family

10.1007/s00253-016-7343-9 · 2016 · External reference

Pediocin‐like antimicrobial peptides (class IIa bacteriocins) and their immunity proteins: biosynthesis, structure, and mode of action

10.1002/psc.699 · 2005 · External reference

Peptide bacteriocins-structure activity relationships

10.2174/1568026615666150812121103 · 2016 · External reference

Structural features, mechanisms of action, and prospects for practical application of class II bacteriocins

10.1134/s0006297922110165 · 2022 · External reference

Structure-function relationships of the non-lanthionine-containing peptide (class II) bacteriocins produced by gram-positive bacteria

10.2174/138920109787048661 · 2009 · External reference

Structural basis of the immunity mechanisms of pediocin-like bacteriocins

10.1128/aem.00481-22 · 2022 · External reference

Structural basis of the mechanisms of action and immunity of lactococcin A, a class IId bacteriocin

10.1128/aem.00066-23 · 2023 · External reference

Recent insights into structure–function relationships of antimicrobial peptides

10.1111/jfbc.12546 · 2019 · External reference

Pediocin-like bacteriocins: new perspectives on mechanism of action and immunity

10.1007/s00294-017-0757-9 · 2018 · External reference

Antioxidant and antimicrobial activity of bacteriocin-producing strains of lactic acid bacteria isolated from the human gastrointestinal tract

10.23751/pn.v19i1.5147 · 2017 · External reference

Effect of crude bacteriocin isolated from locally Lactococcus lactis on cancer cell lines

10.37506/ijfmt.v14i1.57 · 2020 · External reference

Bacteriocins as potential therapeutic approaches in the treatment of various cancers: a review of in vitro studies

10.3390/cancers14194758 · 2022 · External reference

Use of bacteriocins and bacteriocinogenic beneficial organisms in food products: benefits, challenges, concerns

10.3390/foods11193145 · 2022 · External reference

Emerging lactic acid bacteria bacteriocins as anti-cancer and anti-tumor agents for human health

10.1016/j.heliyon.2024.e37054 · 2024 · External reference

Bacteriocins in cancer treatment: mechanisms and clinical potentials

10.3390/biom14070831 · 2024 · External reference

Bacterial peptides and bacteriocins as novel treatment for prostate cancer

10.1007/s10989-023-10544-z · 2023 · External reference

Postbiotics combination synergises the antiproliferative effects of doxorubicin in gastric cancer cells: a cellular and molecular deep dive

10.3390/ijms27010362 · 2025 · External reference

A natural metabolite, nuevamine alkaloid: synthesis, in vitro anticancer, wound healing, DFT and molecular docking studies

10.1016/j.prenap.2026.100797 · 2026 · External reference

Gut microbial postbiotics as potential therapeutics for lymphoma: proteomics insights of the synergistic effects of nisin and urolithin B against human lymphoma cells

10.3390/ijms26146829 · 2025 · External reference

Postbiotics in colorectal cancer: intervention mechanisms and perspectives

10.3389/fmicb.2024.1360225 · 2024 · External reference

Bio‐inspired smart elastin‐like polypeptides (ELPs) for precision drug delivery: molecular strategies, thermal responsiveness, and translational advances

10.1002/adhm.202504112 · 2026 · External reference

Postbiotics: emerging bioactive agents in cancer therapy

10.20892/j.issn.2095-3941.2025.0511 · 2026 · External reference

Postbiotic metabolites produced by Lactobacillus plantarum strains exert selective cytotoxicity effects on cancer cells

10.1186/s12906-019-2528-2 · 2019 · External reference

Using postbiotics from functional foods for managing colorectal cancer: mechanisms, sources, therapeutic potential, and clinical perspectives

10.3390/microorganisms13061335 · 2025 · External reference

Postbiotics, metabolic signaling, and cancer

10.3390/molecules26061528 · 2021 · External reference

Bacteriocin diversity, function, discovery and application as antimicrobials

10.1038/s41579-024-01045-x · 2024 · External reference

Postbiotics as promising tools for cancer adjuvant therapy

10.34172/apb.2021.007 · 2020 · External reference

Investigating postbiotics as innovative adjuvants: deciphering the gut-breast connection in breast cancer therapy, from gut microbiome to personalized medicine

10.1007/s11033-025-10626-9 · 2025 · External reference

Natural bioactive compounds targeting FABP4 in adipogenesis and obesity: evidence from in vitro and in vivo studies

10.3390/ijms27031306 · 2026 · External reference

Harnessing honey bee venom for breast cancer treatment: from molecular insights to nano formulations

10.1016/j.ntm.2026.100120 · 2026 · External reference

Postbiotics and phage synergy in precision oral microbiome engineering: systems biology strategies targeting Streptococcus mutans in dental caries

10.3389/fmolb.2026.1766853 · 2026 · External reference

Human microbiota peptides: important roles in human health

10.1039/d4np00042k · 2025 · External reference

Signaling pathways that control cell proliferation

10.1101/cshperspect.a008904 · 2013 · External reference

From signalling pathways to targeted therapies: unravelling glioblastoma’s secrets and harnessing two decades of progress

10.1038/s41392-023-01637-8 · 2023 · External reference

Targeting Lactobacillus plantarum metabolites to brain cancer cell line pathway

10.21608/ejmm.2026.463892.2146 · 2026 · External reference

Targeting compensatory proliferation signals in oral cancer

10.1016/j.jobcr.2024.05.014 · 2024 · External reference

Cadmium-induced hepatotoxicity: interconnecting molecular and cellular pathways

10.1016/j.tox.2026.154475 · 2026 · External reference

Overcoming resistance to apoptosis in cancer therapy

10.1007/978-1-4020-6554-5_6 · 2008 · External reference

Cancer-associated inflammation: pathophysiology and clinical significance

10.1007/s00432-022-04399-y · 2023 · External reference

Broad targeting of resistance to apoptosis in cancer

10.1016/j.semcancer.2015.03.001 · 2015 · External reference

Targeting mitochondrial apoptosis to overcome treatment resistance in cancer

10.3390/cancers12030574 · 2020 · External reference

Enhanced biomineralization and bone apatite growth formation capacity of chitosan-based electrospun scaffold for bone tissue engineering application

10.1142/s1793984425500059 · 2026 · External reference

Deciphering autophagy-metabolism interactions in cancer drug resistance: a comprehensive review

10.1007/s00280-026-04894-w · 2026 · External reference

Lactobacillus plantarum and its derived bacteriocin exhibits potent antitumor activity against esophageal cancer cells

10.3389/fmicb.2023.1306192 · 2024 · External reference

Postbiotic production: harnessing the power of microbial metabolites for health applications

10.3389/fmicb.2023.1306192 · 2023 · External reference

Targeting inflammation and immune regulation in chronic inflammation associated cancers

10.1111/cas.70360 · 2026 · External reference

Salivary biomarkers and their diagnostic importance in oral diseases

10.1016/j.archoralbio.2026.106595 · 2026 · External reference

Bacteriocins: perspective for the development of novel anticancer drugs

10.1007/s00253-018-9420-8 · 2018 · External reference

Natural resources in oral healthcare: therapeutic potential, clinical evidence, and translational challenges — a scoping review

10.1177/1934578x261449325 · 2026 · External reference

Recombinant bacteriocin rhamnosin suppresses Malignant phenotypes of colorectal cancer cells

10.48048/tis.2025.10057 · 2025 · External reference

Cyanobacterial fatty acid esters disrupt polymicrobial oral biofilms and exhibit potential interactions with adhesion proteins and virulence-associated targets

10.1016/j.archoralbio.2026.106666 · 2026 · External reference

Application of molecular dynamics simulation in self-assembled cancer nanomedicine

10.1186/s40824-023-00386-7 · 2023 · External reference

Targeting glutaminase by natural compounds: structure-based virtual screening and molecular dynamics simulation approach to suppress cancer progression

10.3390/molecules27155042 · 2022 · External reference

Synthesis, characterization, molecular docking and molecular dynamics simulations of benzamide derivatives as potential anti-ovarian cancer agents

10.1016/j.molstruc.2022.133785 · 2022 · External reference

Bacteriocins as natural weapon against cancer: in vitro, in vivo, and in silico perspectives

10.1007/s42452-025-06929-y · 2025 · External reference

Promising future of engineered probiotics for antimicrobial peptides and protein production: prospects and industrial challenges

10.1007/s12602-025-10883-x · 2025 · External reference

Lactic acid bacteria-derived bacteriocins: a promising antimicrobial strategy against multidrug-resistant for neonatal sepsis pathogens

10.1007/s12602-026-10934-x · 2026 · External reference

Commercial utilization of bacteriocins: tackling challenges and exploring their potential as alternatives to antibiotics

10.1080/17460913.2025.2520693 · 2025 · External reference

Bacteriocins in the era of antibiotic resistance: rising to the challenge

10.3390/pharmaceutics13020196 · 2021 · External reference

Assessing the efficacy of postbiotics derived from Lactobacillus plantarum on antibiotic resistance genes in nosocomial pathogens such as Enterococcus faecalis and Pseudomonas aeruginosa

10.1093/lambio/ovae127 · 2024 · External reference

Effect of bacteriocin-like inhibitory substance (BLIS) from Enterococcus faecium DB1 on cariogenic Streptococcus mutans biofilm formation

10.5851/kosfa.2022.e49 · 2022 · External reference